China Overseas Chinese Network, April 27. According to a report compiled by the South American Overseas Chinese News Network, the "Winter 2022" vaccination campaign organized by the Paraguayan Ministry of Health started on April 25 and will end on April 29.

The campaign aims to vaccinate everyone 6 months and older against influenza, vaccinate against Streptococcus pneumoniae for those 60 years and older, and schedule a COVID-19 vaccine on a case-by-case basis.

The Ministry of Health highlights the precautions for vaccinating against the new coronary pneumonia.

first dose

  Paraguay's "El Pais" reported that everyone aged 5 and over can receive the first dose of the new coronary pneumonia vaccine.

Specifically, children aged 5 to 11 are vaccinated with Pfizer’s new crown pneumonia vaccine or China Kexing’s new crown pneumonia vaccine Kerrfall, and adolescents aged 12 to 17 and pregnant women over 12 weeks of pregnancy (must present a signed and stamped medical certificate) are vaccinated with Pfizer’s new crown pneumonia Pneumonia vaccine, other people over 18 years old can be vaccinated with any brand of vaccine provided in Paraguay.

  It should be noted that children and adolescents aged 5 to 17 must be accompanied by their parents or legal guardians when they are vaccinated against COVID-19, and present the ID cards of the inoculated person and accompanying person, as well as a copy of the inoculated person's birth certificate or household registration book.

If the accompanying person is a temporary guardian, a copy of the court certificate must be presented; if a birth certificate or any other document proving paternity cannot be produced, the accompanying person must sign an affidavit certifying the degree of paternity or relationship with the inoculated person.

second dose

  Those who received the first dose of Pfizer’s new coronary pneumonia vaccine must receive the second dose at an interval of 3 weeks; those who received the first dose of AstraZeneca, Moderna, Satellite-V, Sinovac or Sinopharm’s new coronary pneumonia vaccine, 4 weeks apart.

  Children receive the second dose of the new coronary pneumonia vaccine. The interval between the first dose and the first dose depends on the brand of the first dose of the vaccine. Pfizer must be separated by 8 weeks, and Sinovac must be separated by 4 weeks.

  For those who have received the first dose of the new coronary pneumonia vaccine abroad, including children aged 5 to 11, the interval between vaccinations depends on the brand of the first dose of the vaccine, which must be separated by 8 weeks for Pfizer and 4 weeks for Sinovac.

In addition, these individuals must be registered on the Vacunate website for follow-up vaccinations according to the procedures indicated on the website.

The third dose (strengthening injection)

  Adolescents between the ages of 12 and 17 and pregnant women over 12 weeks of pregnancy should receive a third booster dose at least 4 months after the previous dose, which is branded as Pfizer.

  Persons 18 years of age and older, including medical staff, who receive the second dose of Sinovac, Sinopharm, Kovacin, HayatVax, Pfizer, AstraZeneca, Satellite-V or Moderna COVID-19 vaccine, must be separated from the previous dose At least 4 months before the third dose, its brand is Pfizer; the second dose of Johnson & Johnson's new coronary pneumonia vaccine, people must be vaccinated at least 3 months apart, the brand is Pfizer or Moderna.

Fourth dose (Second dose booster)

  People 50 years of age and older, medical staff, and immunocompromised people (12 years and older) can all receive a fourth dose of the new coronary pneumonia vaccine six months after the third booster dose.

(Mao Baekhyun)

Keywords: